Intravitreal foscarnet for cytomegalovirus retinitis in patients with AIDS.
Article
in English
| IMSEAR
| ID: sea-40131
ABSTRACT
To determine the visual outcome, progression, and complications of patients with acquired immuno-deficiency syndrome-related cytomegalovirus (CMV) retinitis treated with intravitrealfoscarnet (2.4 mg in 0.1 ml per injection), a retrospective study was carried out in 193 patients. Induction therapy consisted of two injections a week until the lesions were inactive. Maintenance therapy consisted of one injection a week until relapse, then re-induction was instituted. In 301 treated eyes, visual acuity remained stable in 184 (61%), improved in 16 (5%), and decreased in 101 (34%). Of these, 15 retinal detachments, 13 intravitreal hemorrhages, 3 endophthalmitis, and 2 cataract occurred. Median time of first progression was 15 weeks. Involvement of the fellow eye occurred in 35% of the patients during treatment of the first eye. Intravitreal foscarnet appeared to be a useful alternative treatment for patients intolerant or unaffordable to intravenous anti-CMV drugs, but the complications of this treatment should also be considered.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Antiviral Agents
/
Vitreous Body
/
Aged
/
Female
/
Humans
/
Male
/
Retrospective Studies
/
Treatment Outcome
/
Foscarnet
/
AIDS-Related Opportunistic Infections
Type of study:
Observational study
Language:
English
Year:
2005
Type:
Article
Similar
MEDLINE
...
LILACS
LIS